Attana
0.01 SEK
+11.11 %
Less than 1K followers
ATANA
Nordic SME
Biotechnology & Pharmaceuticals
Health Care
Overview
Financials & Estimates
Ownership
Investor consensus
+11.11 %
-9.09 %
-41.18 %
-54.55 %
+66.67 %
-60.00 %
-90.07 %
-98.43 %
-93.50 %
Attana conducts research and development of pharmaceuticals. The company specialises in vitro characterization of molecular interactions, which is used for analysis in the development of new pharmaceuticals. The company's patented solutions are mainly used in the study of different binding properties and macrostructures in cells, proteins, viruses, and bacteria. Operations are found mainly within the Nordic countries and Europe. The company was established in 2002 is based in Stockholm.
Read moreMarket cap
25.81M SEK
Turnover
61.58K SEK
Revenue
4.1M
EBIT %
-244.15 %
P/E
-
Dividend yield-%
-
Revenue and EBIT-%
Revenue M
EBIT-% (adj.)
EPS and dividend
EPS (adj.)
Dividend %
Financial calendar
27/2
2026
Annual report '25
All
Press releases
3rd party
ShowingAll content types
Sista dag för handel med teckningsoptioner av serie TO3 i Attana
Attana tecknar nytt hyresavtal med UCSD - befintlig kund utökar användningen av Attana Cell™250
Join Inderes community
Don't miss out - create an account and get all the possible benefits
Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools